SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The filing discloses Item 3.01 notification from Nasdaq granting SurgePays an additional 180-calendar-day compliance period (until March 22, 2027) to regain compliance with the minimum $1.00 bid price requirement. The company previously failed to meet this requirement, and failure to cure by the deadline will result in delisting. This is a material delisting risk event that directly threatens the company's continued listing on Nasdaq.
View raw filing on EDGAR →The filing discloses that SilverBox Corp IV's units, Class A ordinary shares, and warrants have been delisted from the New York Stock Exchange effective September 28, 2026, and are now quoted and traded on the OTC Markets under new ticker symbols (SBXUF, SBXDF, SBXWF). This is a material delisting event that materially affects the registrant's listing status and liquidity, even though the company intends to remain a public reporting company.
View raw filing on EDGAR →The Company failed to satisfy Nasdaq's minimum bid price requirement of $1.00 for 30 consecutive business days and was transferred from The Nasdaq Global Select Market to The Nasdaq Capital Market on September 24, 2026. The Company has been granted an additional 180-calendar day compliance period (until March 22, 2027) to regain compliance, with no assurance of success.
View raw filing on EDGAR →HUB Cyber Security received a Nasdaq deficiency notification on September 23, 2026, stating it is not in compliance with Nasdaq Listing Rule 5550(b)(2) requiring a minimum Market Value of Listed Securities (MVLS) of US$35 million. The Company has 180 calendar days until March 22, 2027 to regain compliance, or face delisting proceedings. This is a classic delisting-risk disclosure under Item 3.01 equivalent, materially affecting the registrant's continued listing status and investor assessment.
View raw filing on EDGAR →Flash Sports & Media Holdings' common stock was delisted from Nasdaq on September 25, 2026, and moved to OTC trading under symbol "FLZH". A Nasdaq continued listing hearing is scheduled for October 6, 2026, and the company has applied for OTCQB quotation, creating material uncertainty about the company's future listing status and market liquidity.
View raw filing on EDGAR →The 6-K discloses that Datasea received a Nasdaq staff determination notice on March 27, 2026, for failure to maintain the $1 minimum bid price requirement. Although initially granted a 180-day compliance period until September 23, 2026, the Company was granted an additional 180-day extension on September 24, 2026, until March 22, 2027. The filing explicitly states that if the Company does not regain compliance by the Compliance Date, "Nasdaq will provide written notification that the Company's securities are subject to delisting." This is a material delisting risk disclosure under Item 3.01 equivalent.
View raw filing on EDGAR →The letter discloses a deficiency notification from Nasdaq on March 17, 2026, stating that the Company's closing bid price fell below the $1.00 minimum requirement for 30 consecutive business days, triggering Nasdaq Listing Rule 5550(a)(2). The letter explicitly acknowledges "the risk of delisting" and notes that "options available to rectify this problem...are not guaranteed." This is a material delisting-risk disclosure that would significantly affect investor assessment.
View raw filing on EDGAR →The press release announces that Orion Digital has regained compliance with Nasdaq's minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)) after the stock price fell below US$1.00. This disclosure directly addresses a delisting risk — the Company was previously out of compliance with a continued listing standard and has now cured that deficiency. The announcement of regaining compliance is material because it resolves an existential threat to the Company's exchange listing.
View raw filing on EDGAR →The exhibit announces that the Nasdaq Hearings Panel has denied the Company's request to reinstate trading and determined to delist the Company's securities effective September 23, 2026. The Panel's decision was based on trading activity indicative of potential manipulation and insufficient liquidity. This is a definitive delisting determination (not merely a risk or notice of non-compliance), making it a material event that directly affects the registrant's continued listing status and investor access to the securities.
View raw filing on EDGAR →The exhibit is a press release announcing that Nasdaq has issued a Staff Delisting Determination to delist Premium Catering's Class A Ordinary Shares from The Nasdaq Stock Market, citing concerns about third-party manipulation and insufficient liquidity under Nasdaq Listing Rule IM-5101-4. Although the Company intends to appeal and request a hearing before the Nasdaq Hearings Panel, the delisting determination itself represents a material delisting risk that would directly affect investor assessment of the registrant's continued listing status and market access.
View raw filing on EDGAR →The filing discloses that Nasdaq's Listing and Hearing Review Council has affirmed the delisting of Bayview Acquisition Corp's securities effective after the Company failed to complete its business combination by June 19, 2026. The Company anticipates Nasdaq will file Form 25-NSE to remove the securities from listing and registration, with the Company planning to move to OTC Markets trading. This is a material delisting event under Item 3.01.
View raw filing on EDGAR →The disclosure reports that Gossamer Bio has regained compliance with Nasdaq's minimum bid price requirement (Rule 5450(a)(1)) following a prior non-compliance notice dated April 8, 2026, and a 1-for-80 reverse stock split executed on September 10, 2026. This is a delisting-risk resolution: the company was at risk of delisting due to failure to maintain a $1.00 minimum bid price for 30 consecutive business days, but has now cured that deficiency through the reverse split and price recovery. Material to investors as it directly addresses the company's continued listing status.
View raw filing on EDGAR →Nexalin received a Notice from Nasdaq's Hearings Panel on September 25, 2026, granting conditional continued listing subject to demonstrating compliance with the Minimum Bid Price Requirement by September 28, 2026, and the Stockholders' Equity Requirement by January 4, 2027. The filing explicitly states that "if the Company fails to satisfy the conditions of the Notice, the Company's common stock will be subject to delisting from Nasdaq," and notes there is "no assurance" the Company will meet these conditions. This is a classic delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →Lumen Technologies announced a voluntary transfer of its common stock listing from the NYSE to Nasdaq, with delisting from NYSE effective October 5, 2026, and listing on Nasdaq effective October 6, 2026. While this is a planned, voluntary transition rather than a distress-driven delisting, it constitutes a material transfer of listing that affects trading venue and market accessibility for investors.
View raw filing on EDGAR →The filing discloses a formal notice from NYSE Regulation that the Company has fallen below the continued listing standard (average aggregate global market capitalization of $40 million over 30 trading days) and that delisting proceedings have commenced under Section 802.01B of the NYSE Listed Company Manual. Trading has been suspended and securities will move to OTC markets, representing a material loss of liquidity and market access that would significantly affect investor assessment of the registrant.
View raw filing on EDGAR →The exhibit announces that Alpha Compute has regained compliance with Nasdaq Listing Rule 5550(a)(2) after receiving a deficiency notice on March 2, 2026 for failing to maintain a minimum closing bid price of $1.00 per share. This is a material delisting-risk disclosure: the company faced a concrete threat of delisting due to non-compliance with continued listing standards, and the announcement confirms resolution of that threat. The language "regained compliance" and "the matter is now closed" directly address the prior delisting risk.
View raw filing on EDGAR →Silexion received a formal notice from Nasdaq on September 25, 2026, that its ordinary shares have failed to maintain the minimum $1.00 bid price required under Nasdaq Listing Rule 5550(a)(2) for 30 consecutive business days. The Nasdaq hearings panel will consider whether to allow the company to remain listed on the Nasdaq Capital Market. This is a classic delisting risk disclosure under Item 3.01, materially threatening the company's continued exchange listing.
View raw filing on EDGAR →The successor PubCo notified Nasdaq on September 25, 2026 to suspend trading of the SPAC's units, Class A ordinary shares, and rights, and requested Nasdaq file a Form 25 to delist these securities; the company also intends to file Form 15 to deregister the SPAC's securities and suspend reporting obligations in connection with the business combination closing.
View raw filing on EDGAR →GT Biopharma received a Nasdaq delisting notice on November 20, 2025 for failing to maintain the $1.00 minimum bid price requirement, was granted a 180-day compliance period until November 16, 2026, and on September 22, 2026 notified investors that it has regained compliance by maintaining a closing bid price above $1.00 per share for at least ten consecutive business days. This disclosure directly addresses the resolution of a material delisting risk under Item 8.01 (Other Events).
View raw filing on EDGAR →Netcapital received a notice from Nasdaq on September 21, 2026 stating the company is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to failure to timely file its Form 10-Q and Form 10-K. The company has until October 23, 2026 to submit a compliance plan and until February 9, 2027 to regain compliance, or face potential delisting. This is a classic Item 3.01 delisting-risk disclosure.
View raw filing on EDGAR →The filing discloses receipt of a Nasdaq deficiency notice on September 22, 2026, for failure to timely file the Form 10-Q for the quarter ended July 31, 2026, placing the Company in violation of Nasdaq Listing Rule 5250(c)(1). The Company has 60 days to submit a compliance plan and faces potential delisting if it fails to regain compliance within the prescribed timeframe. This is a direct delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →Calidi received a notice from NYSE American on September 21, 2026, stating non-compliance with the stockholders' equity continued listing standard (Section 1003(a)(ii)), requiring $4.0 million in equity but the company reported only $3.1 million as of June 30, 2026. The company has until October 21, 2026, to submit a compliance plan or face delisting proceedings by March 21, 2028. This is a clear delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →The filing discloses that Nasdaq notified Fusemachines on September 24, 2026, that the Company's securities are subject to delisting due to continued non-compliance with the Market Value of Listed Securities (MVLS) requirement of $50 million. The Company received the initial notice on March 27, 2026, and had until September 23, 2026, to regain compliance. The Company plans to request a hearing before the Nasdaq Hearings Panel, but there is no assurance of continued listing. This is a clear delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →Dyadic received deficiency notices from Nasdaq on September 25, 2026, for failure to maintain (1) minimum bid price of $1 per share and (2) minimum Market Value of Listed Securities of $35 million, both required by Nasdaq Listing Rule 5550. The company has 180 calendar days until March 24, 2027, to regain compliance or face delisting. This is a classic delisting-risk disclosure under Item 3.01, materially threatening the company's continued listing status.
View raw filing on EDGAR →Sanuwave received a Notice from Nasdaq on September 23, 2026, stating that its Market Value of Listed Securities (MVLS) fell below the $50,000,000 minimum required for continued listing on The Nasdaq Global Market under Listing Rule 5450(b)(2)(A). The company has 180 calendar days (until March 22, 2027) to regain compliance, and failure to do so will result in delisting notification. This is a classic delisting-risk disclosure under Item 3.01, materially affecting investor assessment of the registrant's continued exchange listing status.
View raw filing on EDGAR →The exhibit discloses that Innovation Beverage Group received a Nasdaq notice on September 22, 2026, stating it no longer complies with the minimum stockholders' equity requirement of $2,500,000 under Listing Rule 5550(b)(1), with reported stockholders' equity of ($1,469,914) as of December 31, 2025. The Company has 45 days to submit a compliance plan and up to 180 days to evidence compliance, or face delisting. This is a material delisting-risk disclosure under Item 3.01 equivalent.
View raw filing on EDGAR →Southland Holdings received formal notice from NYSE Regulation on September 23, 2026, that it is no longer in compliance with NYSE American's continued listing standards due to a stockholders' deficit of $248.2 million and net losses in three consecutive fiscal years. The company must submit a compliance plan by October 23, 2026, or face delisting proceedings by March 23, 2028. This is a direct notice of delisting risk under Item 3.01, materially affecting the registrant's ability to maintain its public listing.
View raw filing on EDGAR →The filing discloses that Beasley Broadcast Group is no longer compliant with Nasdaq Rule 5605(c)(2)(A) following the death of director Peter A. Bordes, Jr., which reduced the Audit Committee below the required three independent members. The Company has notified Nasdaq and is relying on a cure period expiring September 19, 2027 or at the next annual stockholder meeting to restore compliance. This is a material failure to satisfy a continued listing rule that directly triggers Item 3.01 disclosure requirements.
View raw filing on EDGAR →The press release announces that Trident has regained compliance with Nasdaq Listing Rule 5550(b)(2) after receiving a March 26, 2026 deficiency notice for failing to maintain the minimum market value of listed securities (MVLS) of US$35,000,000. The company was given 180 calendar days to cure the deficiency, and this announcement confirms it has done so by September 21, 2026. This is a material delisting-risk resolution—the company faced potential delisting but has now cured the compliance failure and closed the matter.
View raw filing on EDGAR →The press release announces a 23-for-1 share consolidation explicitly undertaken "to enable the Company to regain compliance with Nasdaq Marketplace Rule 5550(a)(2) and maintain its listing on Nasdaq." This disclosure reveals the company was out of compliance with Nasdaq's minimum bid price rule and faced delisting risk, which it is addressing through the consolidation. This is material to investors as it signals prior listing compliance failure and the remedial action taken.
View raw filing on EDGAR →Waldencast has filed a Form 25 with the SEC to voluntarily delist its Class A Ordinary Shares and Warrants from Nasdaq, with delisting expected to become effective on or about October 4, 2026 and the last trading day expected on or about October 2, 2026. The company also intends to file a Form 15 to suspend its SEC reporting obligations. This is a material event that fundamentally changes the registrant's public-market status and investor access to its securities.
View raw filing on EDGAR →The 6-K discloses that Tantech regained compliance with Nasdaq's minimum bid price requirement (Listing Rule 5550(a)(2)) after previously falling below $1.00 per share for 30 consecutive business days on March 26, 2026. The notification on September 21, 2026 confirms the Company has satisfied the 180-day cure period and is no longer at risk of delisting. This resolves a material delisting risk that threatened the Company's continued listing on Nasdaq.
View raw filing on EDGAR →The filing discloses a 1-for-10 reverse stock split being implemented "to support the Company's efforts to regain compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market." This is a direct response to delisting risk—the company is taking corrective action to avoid loss of listing status. While the reverse split itself is a capital structure event, the material disclosure here centers on the underlying delisting compliance issue.
View raw filing on EDGAR →CytoSorbents regained compliance with Nasdaq's minimum bid price requirement ($1.00 per share) as of September 22, 2026, after 10 consecutive trading sessions at or above that threshold. However, the company remains non-compliant with the Market Value of Listed Securities (MVLS) requirement of $35 million and has until December 28, 2026 to regain compliance or face delisting notification.
View raw filing on EDGAR →Innoviz received a Nasdaq notification on September 22, 2026, granting an additional 180-day compliance period (until March 22, 2027) to regain compliance with the minimum bid price requirement of $1.00 per share. The company failed to regain compliance during the initial 180-day period ending September 21, 2026, and now faces delisting risk if it cannot achieve the required bid price or effect a reverse split before the extended deadline. This is a material disclosure of continued listing failure and delisting risk under Item 3.01 equivalent.
View raw filing on EDGAR →The exhibit announces that IM Cannabis has regained compliance with Nasdaq's minimum bid price requirement (Rule 5550(a)(2)) after the closing bid price remained at $1.00 or greater for 18 consecutive business days. This disclosure directly addresses a delisting risk — the company had previously fallen below the $1.00 minimum and faced potential delisting, and this notice confirms restoration of compliance and closure of the deficiency matter. Material to investors as it resolves an existential listing threat.
View raw filing on EDGAR →The filing discloses a Nasdaq minimum bid price deficiency notice (March 12, 2026) that triggered a 180-day compliance period, followed by a second 180-day extension (September 10, 2026), and ultimately resolution through regaining compliance (September 22, 2026). While the company has now cured the deficiency, the disclosure documents the delisting risk process and its resolution, which is material to investors assessing the registrant's listing status and financial condition.
View raw filing on EDGAR →The filing discloses that Nasdaq announced on September 17, 2026 that it will file a Form 25 with the SEC to complete the delisting of Aditxt's common stock from Nasdaq, with the delisting becoming effective ten days after the Form 25 filing. This is a definitive delisting notice under Item 3.01, not merely a delisting risk—the company's stock was already suspended on June 25, 2026, and Nasdaq has now formally announced the completion of the delisting process. This is material to any investor holding or considering the company's securities.
View raw filing on EDGAR →SCWorx received a Nasdaq delisting decision on September 17, 2026, for failure to satisfy the Publicly Held Shares Rule following a reverse stock split. Although the Company completed a private placement on September 16 to cure the deficiency and submitted a reconsideration request on September 18, it must also achieve a $1.00+ closing bid price for 10 consecutive trading days by October 5, 2026, to regain Bid Price Rule compliance, with risk that Common Stock will not resume trading by October 31, 2026.
View raw filing on EDGAR →The disclosure announces the expiration and delisting of the Company's publicly traded warrants (NTRBW) from Nasdaq effective September 30, 2026. While the warrant expiration is automatic under the Warrant Agreement and does not affect the common stock listing, the removal of a security from Nasdaq listing is a material event affecting warrant holders' ability to trade and exercise their securities. This constitutes a delisting event under Item 3.01 principles, though the common stock itself remains listed.
View raw filing on EDGAR →Sequans received a notice from NYSE on September 14, 2026 that it is no longer in compliance with Section 802.01B of the NYSE Listed Company Manual due to average global market capitalization below $50 million combined with stockholders' equity less than $50 million. While the notice does not result in immediate delisting, the company has 90 days to submit a compliance plan and 9 months to cure the deficiency, or face delisting. This is a material disclosure of delisting risk under Item 3.01 equivalent.
View raw filing on EDGAR →Core AI received a Nasdaq notification on September 18, 2026, that it failed to maintain the minimum shareholders' equity of $2,500,000 required by Nasdaq Listing Rule 5550(b)(1), with shareholders' equity of only $2,429,389 as of June 30, 2026. The company has 45 days to submit a compliance plan and up to 180 days to regain compliance, or face delisting. This is a direct notice of non-compliance with continued listing standards and explicit delisting risk.
View raw filing on EDGAR →Brightline Interactive received a Nasdaq Staff Determination to delist on September 11, 2026, for failing to maintain the minimum $1.00 bid price requirement under Nasdaq Listing Rule 5550(a)(2). The company has appealed the determination and implemented a 1-for-8 reverse stock split to regain compliance with the listing standard.
View raw filing on EDGAR →Fast Track Group announced that Nasdaq will delist its Class A ordinary shares from The Nasdaq Capital Market effective ten days after filing Form 25-NSE with the SEC. The delisting results from the Company's failure to satisfy the US$1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). This is a material event that directly affects the registrant's listing status and trading venue, though the Company will continue trading on OTC Markets and remain a reporting company.
View raw filing on EDGAR →The filing discloses a transfer of listing from Nasdaq Global Market to Nasdaq Capital Market, which is a downgrade in listing tier. While framed as an "approval" and "transfer," this represents a failure to maintain continued listing standards on the higher-tier market and constitutes a material change in the company's exchange listing status. The transfer to the Capital Market tier signals the company no longer meets the financial or governance requirements of the Global Market.
View raw filing on EDGAR →The exhibit discloses that Immutep received a Nasdaq deficiency notice on 30 April 2026 for failing to maintain a minimum bid price of US$1.00 for 30 consecutive business days, triggering a compliance period ending 26 October 2026. The ADS ratio change (1:20 reverse split) is explicitly a "technical step directed at that requirement" to regain compliance. This is a material delisting risk disclosure under Item 3.01, as the company faces potential delisting if it cannot achieve the required minimum bid price within the compliance window.
View raw filing on EDGAR →The press release announces that CollPlant has regained compliance with Nasdaq Listing Rule 5550(a)(2) following a deficiency notice received on March 23, 2026 for trading below the $1.00 minimum bid price. The notification confirms the company has satisfied the continued listing requirement and the matter is formally closed. This disclosure directly addresses delisting risk — the resolution of a prior failure to satisfy a continued listing rule, which is material to investors assessing the registrant's exchange listing status.
View raw filing on EDGAR →Reborn Coffee received a notice from Nasdaq on September 16, 2026, that it failed to maintain the minimum stockholders' equity of $2,500,000 required under Nasdaq Listing Rule 5550(b)(1), with reported equity of only $735,642. The company has 45 days to submit a compliance plan or face potential delisting, making this a clear delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →The press release announces that Scinai has regained compliance with Nasdaq's $1.00 minimum bid price requirement (Listing Rule 5550(a)(2)) after previously failing to maintain that threshold on March 12, 2026. The company's ADSs had fallen below $1.00 for 30 consecutive business days, triggering a delisting risk notice. This disclosure directly addresses a continued listing rule violation and its resolution, which is material to investors assessing the registrant's ability to remain listed on Nasdaq.
View raw filing on EDGAR →The filing discloses a delisting notice from Nasdaq regarding failure to maintain the minimum bid price requirement ($1.00 per share for 30 consecutive business days), followed by subsequent regaining of compliance. Although the Company ultimately regained compliance, the initial delisting notice and the regulatory process constitute a material delisting-risk event that would affect investor assessment of the registrant's listing status and financial condition.
View raw filing on EDGAR →